Form 4: Accolade CFO Stephen Barnes Reports Stock Transactions Following RSU Vesting
SEC Form 4 Filing
Accolade's Chief Financial Officer, Stephen Barnes, executed transactions involving company stock, including the vesting of restricted stock units and a sale to cover tax obligations.
Summary
- Stephen Barnes, the Chief Financial Officer of Accolade, Inc., reported transactions involving the company's stock.
- On November 11, 2024, 770 restricted stock units (RSUs) vested and converted into 770 shares of common stock.
- On November 12, 2024, 223 shares were sold at a price of $3.638 per share.
- The sale of shares was to cover tax withholding obligations related to the vesting of the RSUs and was not a discretionary sale by Mr. Barnes.
- Following these transactions, Mr. Barnes beneficially owns 204,999 shares of Accolade common stock.
Sentiment
Score: 7
Explanation: The document reflects standard executive compensation practices and does not indicate any positive or negative sentiment. It is a routine filing.
Industry Context
This is a routine filing related to executive compensation and is common for publicly traded companies. It reflects the vesting schedule of equity awards and the subsequent sale of shares to cover tax liabilities.
Comparison to Industry Standards
- The vesting schedule of the RSUs, with one-third vesting after one year and the remainder vesting monthly over the following two years, is a common practice in the tech industry for employee retention.
- The 'mandatory sell to cover' transaction is a standard mechanism for handling tax obligations related to equity compensation, ensuring compliance with tax laws and simplifying the process for employees.
- Many companies, such as Teladoc Health and Livongo, use similar equity compensation structures for their executives.
Stakeholder Impact
- The transactions have a minor impact on shareholders as they involve a small number of shares compared to the total outstanding shares.
- The sale of shares to cover tax obligations is a standard practice and does not indicate any change in the company's financial health or outlook.
Key Dates
| Date | Description |
|---|---|
| 06/10/2022 | June 2022 RSU Vesting Commencement Date, used to calculate the vesting schedule of the restricted stock units. |
| 11/11/2024 | Date of RSU vesting and conversion to common stock. |
| 11/12/2024 | Date of stock sale to cover tax obligations. |
| 11/13/2024 | Date the Form 4 was signed. |
Keywords
Accolade, Stephen Barnes, CFO, restricted stock units, RSU, stock sale, tax withholding, insider trading, Form 4
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.